Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
Part of paid clinical trials in Nashville, Tennessee.
- Sponsor
- Vanderbilt University Medical Center
- Study ID
- NCT00898638
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- biologic sample preservation procedure — OTHER
- medical chart review — OTHER
Study Details
RATIONALE: Collecting and storing samples of tissue, saliva, and blood from patients with cancer and from healthy participants to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing tissue samples from patients with head and neck cancer and from healthy participants.
Key Dates
- Start date
- Feb 13, 2003
- Status verified
- Oct 2025
- Primary completion
- Dec 31, 2050
- Completion
- Dec 31, 2050
Study Design
- Enrollment
- 8,000 participants (estimated)
Arms
- Arm: Healthy VolunteersNon-tumor volunteers will be asked to participate at the time that they are attending a head and neck cancer screening clinic or at the time they are accompanying a patient to their appointment at the head and neck clinic. Intake sheets and biological specimens contributed by volunteers will be coded at the time of collection so that no identifiers are obtained. These specimens will not be linked to identifiers.
- Arm: Head and Neck Tumor patientsEligible patients will be identified at the Vanderbilt Head \& Neck Clinic by clinical and research staff. An appropriately trained staff member will discuss the protocol with the patient (including, risks, benefits, alternatives, etc.).
Primary Outcome Measure
Maintenance of a clinical database pertaining to diagnosis and treatment outcome of patients with head and neck cancer [ Time Frame: ongoing ]
Central Contacts
- Brandee Brown615-936-4896
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37232-6838 | Clinical Trials Office - Vanderbilt-Ingram Cancer Center 800-811-8480 |
| Vanderbilt-Ingram Cancer Center - Cool Springs | Nashville | Tennessee | 37064 | Eben Rosenthal, MD 800-811-8480 |
| Vanderbilt-Ingram Cancer Center at Franklin | Nashville | Tennessee | 37064 | Eben Rosenthal, MD 800-811-8480 |
| Veterans Affairs Medical Center - Nashville | Nashville | Tennessee | 37212 | Clinical Trials Office - Veterans Affairs Medical Center - Nas 615-327-4751 |
Find similar trials in Nashville, TN
By condition
Related Studies
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)PHASE1/PHASE2 · Recruiting · PMV Pharmaceuticals, Inc · Irvine, California
- Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck CancerPHASE1/PHASE2 · Recruiting · Natalie Lockney · Nashville, Tennessee
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseRecruiting · Adela, Inc · Duarte, California
- Intraoperative Ansa Cervicalis Nerve (ACN) StimulationRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee